Skip to main content
Elekta logo

Elekta — Investor Relations & Filings

Ticker · EKTA ISIN · SE0000163628 LEI · 54930044O54BK617EP80 ST Manufacturing
Open in API
Filings indexed 1,124 across all filing types
Latest filing 2020-02-20 Earnings Release
Country SE Sweden
Listing ST EKTA

About Elekta

https://www.elekta.com/

Elekta is a company specializing in precision radiation medicine. It develops and provides clinical solutions, including equipment and software, for treating cancer and brain disorders. The company's portfolio features linear accelerators, the Elekta Unity MR-Linac system, Leksell Gamma Knife for stereotactic radiosurgery, and comprehensive brachytherapy solutions. Elekta also offers oncology informatics software to support treatment planning and clinical workflow. A key focus is advancing adaptive radiotherapy, a personalized approach that utilizes real-time imaging to precisely target tumors and minimize exposure to healthy tissue, aiming to improve patient outcomes.

Recent filings

Filing Released Lang Actions
Earnings Release 2019
Earnings Release Classification · 1% confidence The document text contains key financial metrics for a specific reporting period, explicitly mentioning 'Q3' (Tredje kvartalet) and 'Delårsperiod nio månader' (Nine months period). It details revenue, gross margin, EBITA, and earnings per share, comparing current figures to the previous year. The text concludes with a statement regarding regulatory disclosure: "Detta är sådan information som Elekta AB (publ) är skyldigt att offentliggöra enligt EU:s marknads-missbruksförordning... den 20 feb 2020 kl. 07.30 CET." This structure—detailed financial results for a period shorter than a full year (Q3 and 9 months) combined with a formal disclosure statement—is characteristic of an Interim/Quarterly Report. It is more comprehensive than a simple Earnings Release (ER) but is not the full Annual Report (10-K). Therefore, the classification is Interim / Quarterly Report (IR). Q3 2019
2020-02-20 Swedish
Interim / Quarterly Report 2020
Interim / Quarterly Report Classification · 1% confidence The document is a comprehensive financial report for the third quarter and the first nine months of the fiscal year 2019/20 for Elekta AB. It contains detailed financial statements, including order intake, net sales, EBITA, earnings per share, and cash flow, along with management's analysis of regional performance and business outlook. It is not an announcement of a report, but the report itself, and it contains substantive financial data, fitting the definition of an Interim/Quarterly Report. Q3 2020
2020-02-20 English
Korrigering av pressmeddelande avseende: Québec förvärvar avancerade linjäracceleratorer för att tillgodose det ökande behovet av avancerad cancervård
Regulatory Filings Classification · 1% confidence The document is a press release titled "Korrigering av pressmeddelande avseende: Québec förvärvar avancerade linjäracceleratorer..." (Correction of press release regarding: Quebec acquires advanced linear accelerators...). It announces a contract award ('sole source-kontrakt') for Elekta to supply linear accelerators to the Quebec government authority (GACEQ) for approximately 56 million CAD. This is a specific corporate announcement regarding a major business transaction (a large contract win) but does not fit neatly into standard SEC filings like 10-K, ER, or IR. The text concludes with a statement that the information is required to be disclosed under the EU Market Abuse Regulation (MAR) and provides contact information for Corporate Communications and Investor Relations. This type of material, announcing a significant commercial event or contract, is best classified as a general Regulatory Filing (RNS) or potentially a Capital/Financing Update (CAP) if it significantly impacts capital structure, but given the nature of a contract win announcement often disclosed via regulatory channels, RNS is the most appropriate general category for non-standard, mandatory disclosures, or it could be considered a general announcement of corporate activity. Since it is a specific announcement of a major contract, and not a standard financial report, RNS (Regulatory Filings/General Regulatory Announcements) serves as the best fit among the provided options for a non-standard, mandatory disclosure.
2020-02-17 Swedish
Correction regarding press release: Québec to acquire advanced linear accelerators to meet growing need for advanced cancer care
Regulatory Filings Classification · 1% confidence The document is a press release titled 'Correction regarding press release: Québec to acquire advanced linear accelerators...'. It announces a contract award, provides financial details (CAD 56 million), includes quotes from the CEO, and concludes with contact information and a statement about compliance with the EU Market Abuse Regulation (MAR) regarding information disclosure. This structure strongly indicates an official announcement of a significant business event or contract, which is typically categorized as an Earnings Release (ER) if it contains key financial highlights, or a Regulatory Filing (RNS) if it's a general disclosure. Since it details a specific contract award and value, it functions as a material event disclosure. Given the options, 'ER' (Earnings Release) is often used for material financial news announcements, but 'RNS' (Regulatory Filings) is a broader category for mandatory disclosures under regulations like MAR that don't fit other specific types. However, this is a specific business development announcement, not a standard earnings report. Since it is a formal announcement of a material event (contract award) and includes contact info for IR/Corp Comms, it fits best under the general 'Regulatory Filings' (RNS) category as a mandatory disclosure under MAR, or potentially 'CAP' if interpreted as a major contract impacting future revenue, but RNS is the safest fallback for MAR-related disclosures not covered elsewhere. Given the content is a specific business update rather than a general earnings summary, RNS is appropriate as a catch-all for mandatory regulatory disclosures.
2020-02-17 English
Québec förvärvar 12 linjäracceleratorer Elekta Versa HD för att tillgodose det ökande behovet av avancerad cancervård
Regulatory Filings Classification · 1% confidence The document is a press release announcing a significant contract win by Elekta from a government authority in Québec (GACEQ) for the purchase of 12 linear accelerators. It details the order value (CAD 38.5 million), revenue recognition schedule, and the strategic importance of the purchase for cancer care in the province. The text concludes with a statement indicating that the information is required to be disclosed under the EU Market Abuse Regulation (MAR) and specifies the release time (February 11, 2020, 17:30 CET). This structure—a formal announcement of a material event or contract, often referencing regulatory disclosure requirements—is characteristic of a general regulatory announcement or press release that doesn't fit a specific financial report category like 10-K, ER, or IR. Since it is a formal announcement of a material business event and not a specific financial report, the most appropriate general category is Regulatory Filings (RNS), which serves as a fallback for such official disclosures not covered elsewhere.
2020-02-11 Swedish
Québec to acquire 12 Elekta Versa HD linear accelerators to meet growing need for advanced cancer care
Regulatory Filings Classification · 1% confidence The document announces a significant business contract award to Elekta from the Québec government for the purchase of 12 linear accelerators, detailing the order value (CAD 38.5 million) and revenue recognition schedule across fiscal years (Q4 2019/20 and subsequent years). This is a material event concerning a major transaction/contract. It is not a standard periodic financial report (10-K, IR, ER), a management discussion (MDA), or a proxy statement (DEF 14A). It is a specific announcement of a major business development/contract win. While it involves financing/capital in the sense of a large sale, the most fitting category for a major contract announcement that isn't explicitly about fundraising or M&A is often a general regulatory announcement or a specific category if available. Given the options, this is a significant corporate event announcement. It is not a standard Earnings Release (ER) as it focuses on a specific contract, not overall period results. It is not a Capital/Financing Update (CAP) as it's a sales contract, not debt/equity issuance. It is not M&A (TAR). Since it is a material announcement that doesn't fit the specific financial report types, it falls best under a general regulatory announcement category. The text concludes with a statement indicating it is information Elekta is obliged to make public pursuant to the EU Market Abuse Regulation (MAR), which strongly suggests a regulatory disclosure. Therefore, 'Regulatory Filings' (RNS) is the most appropriate fallback for a material, non-standard disclosure.
2020-02-11 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.